×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
AMLX – amylyx pharmaceuticals, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
AMLX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/19
06:20 am
amlx
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) was upgraded by analysts at Baird R W from a "hold" rating to a "strong-buy" rating.
Low
Report
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) was upgraded by analysts at Baird R W from a "hold" rating to a "strong-buy" rating.
11/18
08:06 am
amlx
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) was upgraded by analysts at Robert W. Baird from a "neutral" rating to an "outperform" rating. They now have a $11.00 price target on the stock, up previously from $3.00.
Medium
Report
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) was upgraded by analysts at Robert W. Baird from a "neutral" rating to an "outperform" rating. They now have a $11.00 price target on the stock, up previously from $3.00.
11/9
10:22 am
amlx
Amylyx Pharmaceuticals Third Quarter 2024 Earnings: US$1.07 loss per share (vs US$0.31 profit in 3Q 2023) [Yahoo! Finance]
Medium
Report
Amylyx Pharmaceuticals Third Quarter 2024 Earnings: US$1.07 loss per share (vs US$0.31 profit in 3Q 2023) [Yahoo! Finance]
11/8
02:21 am
amlx
Amylyx Pharmaceuticals Inc (AMLX) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ... [Yahoo! Finance]
Low
Report
Amylyx Pharmaceuticals Inc (AMLX) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ... [Yahoo! Finance]
11/7
07:00 am
amlx
Amylyx Pharmaceuticals Reports Third Quarter 2024 Financial Results
Medium
Report
Amylyx Pharmaceuticals Reports Third Quarter 2024 Financial Results
11/4
09:00 am
amlx
Amylyx Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 7, 2024
Low
Report
Amylyx Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 7, 2024
10/23
07:09 am
amlx
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) was upgraded by analysts at Bank of America Co. from a "neutral" rating to a "buy" rating. They now have a $10.00 price target on the stock, up previously from $4.20.
Low
Report
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) was upgraded by analysts at Bank of America Co. from a "neutral" rating to a "buy" rating. They now have a $10.00 price target on the stock, up previously from $4.20.
10/18
03:32 pm
amlx
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) was given a new $4.00 price target on by analysts at Leerink Partners. They now have a "market perform" rating on the stock.
Medium
Report
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) was given a new $4.00 price target on by analysts at Leerink Partners. They now have a "market perform" rating on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
11/7/2024
07:00 am
amlx
amylyx pharmaceuticals, inc.
MISS
Report
9.0%
amylyx pharmaceuticals, inc.
8/8/2024
07:00 am
amlx
amylyx pharmaceuticals, inc.
MISS
Report
-7.2%
amylyx pharmaceuticals, inc.
5/9/2024
07:00 am
amlx
amylyx pharmaceuticals, inc.
MISS
Report
-1.6%
amylyx pharmaceuticals, inc.
2/22/2024
07:00 am
amlx
amylyx pharmaceuticals, inc.
MISS
Report
23.4%
amylyx pharmaceuticals, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/12
01:23 pm
amlx
Form SC 13G/A Amylyx Pharmaceuticals, Filed by: VANGUARD GROUP INC
Low
Report
Form SC 13G/A Amylyx Pharmaceuticals, Filed by: VANGUARD GROUP INC
11/7
08:23 am
amlx
Form 10-Q Amylyx Pharmaceuticals, For: Sep 30
High
Report
Form 10-Q Amylyx Pharmaceuticals, For: Sep 30
11/7
07:08 am
amlx
Form 8-K Amylyx Pharmaceuticals, For: Nov 07
Medium
Report
Form 8-K Amylyx Pharmaceuticals, For: Nov 07
11/6
07:25 pm
amlx
Form 4 Amylyx Pharmaceuticals, For: Nov 04 Filed by: Klee Justin B.
Medium
Report
Form 4 Amylyx Pharmaceuticals, For: Nov 04 Filed by: Klee Justin B.
11/4
10:57 am
amlx
Form SC 13G Amylyx Pharmaceuticals, Filed by: VANGUARD GROUP INC
Low
Report
Form SC 13G Amylyx Pharmaceuticals, Filed by: VANGUARD GROUP INC
10/25
05:38 pm
amlx
Form SC 13G Amylyx Pharmaceuticals, Filed by: PERCEPTIVE ADVISORS LLC
Low
Report
Form SC 13G Amylyx Pharmaceuticals, Filed by: PERCEPTIVE ADVISORS LLC
10/17
09:13 am
amlx
Form 8-K Amylyx Pharmaceuticals, For: Oct 17
Medium
Report
Form 8-K Amylyx Pharmaceuticals, For: Oct 17
10/2
06:54 pm
amlx
Form 4 Amylyx Pharmaceuticals, For: Sep 30 Filed by: Klee Justin B.
Low
Report
Form 4 Amylyx Pharmaceuticals, For: Sep 30 Filed by: Klee Justin B.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: